BMC Infectious Diseases · 2019 · 37 citations · 32 references
MedicineInfectious DiseasesPathologyDiagnostic MicrobiologyMedical MicrobiologyMolecular DiagnosticsInfectious Disease DetectionInfectious Disease Molecular TestingPulmonary InfectionsRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Pathogen DiagnosticsBronchoscopyDiagnostic BronchoscopyDiagnostic SensitivityHigh-sensitivity AssaysHiv-associated Opportunistic InfectionsPneumocystis InfectionPneumonia DiagnosisRetrospective Case Ascertainment
BACKGROUND: Pneumocystis jirovecii pneumonia (PCP) is one of the most common HIV-related opportunistic infections. The diagnosis of PCP is based on analyses from respiratory tract specimens which may require the invasive procedure of a diagnostic bronchoscopy. The objective of this study was to evaluate the diagnostic potential of Pneumocystis jirovecii PCR in serum combined with the 1,3-β-D-glucan (betaglucan) test for the diagnosis of PCP in HIV-infected patients. METHODS: cell counts, and 18 blood donors. The serum samples were analyzed for Pneumocystis jirovecii PCR and betaglucan. The reference standard for PCP was based on previously described microbiological and clinical criteria. RESULTS: All patients with PCP had detectabe Pneumocystis jirovecii DNA in serum yielding a sensitivity for the Pneumocystis jirovecii PCR assay in serum of 100%. All blood donors had negative Pneumocystis PCR in serum. The specificity when testing HIV-infected patients was 71%, but with a PCR Cycle threshold (Ct) value of 34 as cut-off the specificity was 90%. At a putative pretest probaility of 20%, the negative and positive predictive value for the Pneumocystis PCR assay in serum was 0.99 and 0.71, respectively. Betaglucan with cut-off level 200 pg/ml combined with a positive Pneumocystis jirovecii PCR result had sensitivity and specificity of 92 and 90%, respectively. The concentration of Pneumocystis jirovecii DNA in serum samples, expressed by the PCR Ct values, correlated inversely to the betaglucan levels in serum. CONCLUSION: In this case-control study including 70% of all HIV-infected patients with PCP treated at Sahlgrenska University Hospital during a time period of 13 years, Pneumocystis PCR analysis on serum samples had a very high sensitivity and negative predictive value for the diagnosis of PCP in HIV-infected patients. A serum-based diagnostic procedure either based on Pneumocystis jirovecii PCR alone or in combination with betaglucan analysis may thus be feasible and would facilitate the care of HIV-infected patients with suspected PCP.
32
AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study
Kate Buchacz, Rose Baker, Frank J. Palella et al. · AIDS · 2010 · 328 citations
Public Health, Infectious Diseases, Epidemiologic Methods +15
Henry Masur, J. T. Brooks, Constance A. Benson et al. · Clinical Infectious Diseases · 2014 · 266 citations · Full text
Otávio T. Ranzani, Elena Prina, Rosario Menéndez et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 180 citations · Full text
Magnus Gisslén, Veronica Svedhem, L Lindborg et al. · HIV Medicine · 2016 · 175 citations · Full text